BNP Paribas Asset Management
Edit

BNP Paribas Asset Management

https://www.bnpparibas-am.com/en/
Last activity: 11.08.2026
Active
Categories: BusinessCorporateFastFinTechFutureInvestmentITManagementProviderService
BNP Paribas Asset Management is the dedicated asset management business line of BNP Paribas.
Likes
3.32K
Followers
160.36K
Website visits
102.5K /mo.
Mentions
29
Location: France, Ile-de-France, Paris
Employees: 10001+

Investors 1

Mentions in press and media 29

DateTitleDescription
12.08.2026Vedanta Biosciences Secures $60M for Groundbreaking Microbiome TherapyVedanta Biosciences secured $60 million in new capital. The Cambridge, MA biopharma advances microbiome-based oral therapies. Funds fuel its pivotal Phase 3 RESTORATiVE303 study. This trial targets recurrent C. difficile infection. Investor...
11.08.2026Vedanta Biosciences Nabs $60M Financing Round CAMBRIDGE, MA, Vedanta Biosciences has secured $60 million in funding. >> Click here for more funding data on Vedanta Biosciences >> To export Vedanta Biosciences funding data to PDF and Excel, click here Vedanta Biosciences, a...
06.08.2026Vedanta Biosciences Raises $60M in FundingVedanta Biosciences, a Cambridge, MA-based provider of microbiome-based oral therapies for gastrointestinal diseases, raised $60M in funding. The round was led by AMR Action Fund and BNP Paribas Asset Management Alts, with participation fro...
16.07.2026Rize lands $31m to help rice farmers cut methane emissions, water usageSingapore-based Rize has raised $31 million in Series B funding from a mix of climate-focused and development finance investors, bringing its total funding to $47 million. The company’s goal is to cut emissions and water use in rice farming...
16.07.2026Singapore’s Rize Raises $31M to Scale Low-Emission Rice Farming Across Asia5 Mins Read Singaporean agritech startup Rize has closed a $31M Series B investment to aggressively expand sustainable, low-methane rice farming across Southeast Asia. Rize, a Singapore-based startup futureproofing rice production, has secu...
08.07.2026Why even gilts are outperforming the once unstoppable Magnificent 7 this yearPlagued by sticky inflation and spendthrift politicians, the UK government’s bonds have spent years as an unloved asset class. But six months into 2026 and they have, so far, outperformed the Magnificent 7. Ali Lyon examines what has gone w...
06.07.2026ReproNovo announces first participant dosed in EU Phase 2 Trial of RPN-002 for Embryo Implantation- RPN-002 is an orally administered oxytocin receptor antagonist aiming to improve IVF/ICSI success rates - The NORDIC study marks an important step in advancing ReproNovo’s global Phase 2 pipeline acrossfertility and women’s health, with f...
30.06.2026BNP Paribas AM Alts raises almost €1bn for second Agility co-investment fund BNP Paribas Asset Management Alternatives has pulled in almost €1bn at the final close of its second Agility private e
15.06.2026SoftBank surges more than 10% as Iran-U.S. deal sends Asia tech stocks soaringJapanese tech investor SoftBank was the best performer among major tech stocks in Asia, rising over 12%. Moves follow a risk-on sentiment amid expectations that the Middle East conflict could end soon, as the U.S. and Iran have reached a pe...
21.05.2026Next faces shareholder pressure over worker payShareholders in Next are set to put pressure on the retail giant to take action on its “reliance” on low-paid labour. At Next’s annual general meeting on Thursday, a group of investors will call on the retailer to take further action on wor...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In